Overview

Study to Evaluate Safety & Efficacy of WC3011 in Postmenopausal Women With Dyspareunia

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if WC3011 is safe and effective in treating the symptom of painful intercourse secondary to vulvovaginal atrophy as measured by subject self-assessment when compared to vehicle.
Phase:
Phase 3
Details
Lead Sponsor:
Warner Chilcott
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate